Landmarks, 2017 Issue

Newsletter for the Nathan Manilow Sculpture Park at Governors State University.https://opus.govst.edu/nmsp_landmarks/1010/thumbnail.jp

Real time PCR assay for the detection of CMV using eclipse hybridization probes

PosterWe developed a qualitative real time PCR assay to detect CMV in patient samples, using a novel hybridization probe termed the Eclipse probe (Epoch Biosciences). These are single probes with a fluorescent molecule attached to the 3' end and a dark quencher on the 5' end. Also conjugated to the 5' end of the probe is a minor groove binding moiety that stabilizes probe binding and allows much shorter probe sequences to be used. The assay is run on the HT7900 Sequence Detection System (Applied Biosystems) in a 96-well plate. We incorporated a heterologous internal control in the assay to monitor the extraction process and detect PCR inhibition. The internal control target is a plasmid, containing a fusion of GFP and C. elegans DNA. We validated ten sample types (spinal fluid, plasma, serum, amniotic fluid, ocular fluid, buffy coat, tissue, urine, bone marrow and bronchioalveolar lavage), and demonstrated the dependence that the limit of detection has on sample type. Since this assay went on-line last year, we have identified a number of patient samples that generated discrepant results between our qualitative test and the Roche CMV Amplicor Quantitative assay. Here we present the validation data for our real time assay, and results of the discrepant analysis

Breakthrough Propulsion Study: Assessing Interstellar Flight Challenges and Prospects

Progress toward developing an evaluation process for interstellar propulsion and power options is described. The goal is to contrast the challenges, mission choices, and emerging prospects for propulsion and power, to identify which prospects might be more advantageous and under what circumstances, and to identify which technology details might have greater impacts. Unlike prior studies, the infrastructure expenses and prospects for breakthrough advances are included. This first year's focus is on determining the key questions to enable the analysis. Accordingly, a work breakdown structure to organize the information and associated list of variables is offered. A flow diagram of the basic analysis is presented, as well as more detailed methods to convert the performance measures of disparate propulsion methods into common measures of energy, mass, time, and power. Other methods for equitable comparisons include evaluating the prospects under the same assumptions of payload, mission trajectory, and available energy. Missions are divided into three eras of readiness (precursors, era of infrastructure, and era of breakthroughs) as a first step before proceeding to include comparisons of technology advancement rates. Final evaluation "figures of merit" are offered. Preliminary lists of mission architectures and propulsion prospects are provided

Novel Gd Nanoparticles Enhance Vascular Contrast for High-Resolution Magnetic Resonance Imaging

Gadolinium (Gd), with its 7 unpaired electrons in 4f orbitals that provide a very large magnetic moment, is proven to be among the best agents for contrast enhanced MRI. Unfortunately, the most potent MR contrast agent based on Gd requires relatively high doses of Gd. The Gd-chelated to diethylene-triamine-penta-acetic acid (DTPA), or other derivatives (at 0.1 mmole/kg recommended dose), distribute broadly into tissues and clear through the kidney. These contrast agents carry the risk of Nephrogenic Systemic Fibrosis (NSF), particularly in kidney impaired subjects. Thus, Gd contrast agents that produce higher resolution images using a much lower Gd dose could address both imaging sensitivity and Gd safety.To determine whether a biocompatible lipid nanoparticle with surface bound Gd can improve MRI contrast sensitivity, we constructed Gd-lipid nanoparticles (Gd-LNP) containing lipid bound DTPA and Gd. The Gd-LNP were intravenously administered to rats and MR images collected. We found that Gd in Gd-LNP produced a greater than 33-fold higher longitudinal (T(1)) relaxivity, r(1), constant than the current FDA approved Gd-chelated contrast agents. Intravenous administration of these Gd-LNP at only 3% of the recommended clinical Gd dose produced MRI signal-to-noise ratios of greater than 300 in all vasculatures. Unlike current Gd contrast agents, these Gd-LNP stably retained Gd in normal vasculature, and are eliminated predominately through the biliary, instead of the renal system. Gd-LNP did not appear to accumulate in the liver or kidney, and was eliminated completely within 24 hrs.The novel Gd-nanoparticles provide high quality contrast enhanced vascular MRI at 97% reduced dose of Gd and do not rely on renal clearance. This new agent is likely to be suitable for patients exhibiting varying degrees of renal impairment. The simple and adaptive nanoparticle design could accommodate ligand or receptor coating for drug delivery optimization and in vivo drug-target definition in system biology profiling, increasing the margin of safety in treatment of cancers and other diseases

Exile Vol. XXIX No. 1

Once by Kate Silliman 1 Mute by Robert Youngblood 1 Photo by Walter Gunn 2 Cactus Man by Bruce Pedretti 3 From Years On Nauset Beach by 4 Lazy Days of The Matter That Fills You With Guild (And Ecstacy) by Eric Stevenson 5 Tennessee Friday by Becky Hinshaw 6 Photo by Jenny Gardner 7 Street Opera by Bill Hayes 7 Antonia by Ruth Wick 8 Photo by Sheila Waters 9 Tunnel Vision by Jeff Reynold 10 Mrs. Matthews by Kate Reynolds 10 A White Mountain by Ruth Wick 11 The Last Days Of Oliver Descantes by Jeff Hamilton 12-23 Photo by Christopher Hooper 24 Baptism by Becky Hinshaw 25 Sunday Afternoon by August West 26 The Joke\u27s On by Christopher B. Broughm 26 Photo by Mark Baganz 27 Blues by Dave Rheingold 28 Speaking To You Through Derision by Jeff Hamilton 29 Photo by Jenny Gardner 30 Northern Lights by Adrienne Wehr 31 Tripping On The Yawn Of Tomorrow by Kate Reynolds 32 Cleo by Kim Kiefer 33 Kuei Mei by Amy Pence 34 Drawing by Peter Brooke 35 Cover Drawing by Peter Brooke -title pag

Simulation Based Training Improves Airway Management for Helicopter EMS Teams

The use of paralytic medications in the performance of RSI intubation is a high risk intervention used by many HEMS crews. There is no margin for error in RSI intubation as the results can be fatal. Operating room access for airway management training has become more difficult, and is not representative of the environment in which HEMS crews typically function. LifeEvac of Virginia designed and implemented an SST airway management program to provide a realistic, consistent training platform. The dynamic program incorporates standardized scenarios, and real life challenging cases that this and other programs have encountered. SST is done in a variety of settings including the helicopter, back of ambulances, staged car crashes and simulation centers. The result has been the indoctrination of a well defined, consistent approach to every airway management intervention. The SST program facillitates enhancement of technical skills. as well as team dynamics and communication

Narrow optical linewidths in erbium implanted in TiO2_2

Atomic and atom-like defects in the solid-state are widely explored for quantum computers, networks and sensors. Rare earth ions are an attractive class of atomic defects that feature narrow spin and optical transitions that are isolated from the host crystal, allowing incorporation into a wide range of materials. However, the realization of long electronic spin coherence times is hampered by magnetic noise from abundant nuclear spins in the most widely studied host crystals. Here, we demonstrate that Er$^{3+}$ ions can be introduced via ion implantation into TiO$_2$, a host crystal that has not been studied extensively for rare earth ions and has a low natural abundance of nuclear spins. We observe efficient incorporation of the implanted Er$^{3+}$ into the Ti$^{4+}$ site (40% yield), and measure narrow inhomogeneous spin and optical linewidths (20 and 460 MHz, respectively) that are comparable to bulk-doped crystalline hosts for Er$^{3+}$. This work demonstrates that ion implantation is a viable path to studying rare earth ions in new hosts, and is a significant step towards realizing individually addressed rare earth ions with long spin coherence times for quantum technologies

Strong Purcell enhancement of an optical magnetic dipole transition

Engineering the local density of states with nanophotonic structures is a powerful tool to control light-matter interactions via the Purcell effect. At optical frequencies, control over the electric field density of states is typically used to couple to and manipulate electric dipole transitions. However, it is also possible to engineer the magnetic density of states to control magnetic dipole transitions. In this work, we experimentally demonstrate the optical magnetic Purcell effect using a single rare earth ion coupled to a nanophotonic cavity. We engineer a new single photon emitter, Er$^{3+}$ in MgO, where the electric dipole decay rate is strongly suppressed by the cubic site symmetry, giving rise to a nearly pure magnetic dipole optical transition. This allows the unambiguous determination of a magnetic Purcell factor $P_m=1040 \pm 30$. We further extend this technique to realize a magnetic dipole spin-photon interface, performing optical spin initialization and readout of a single Er$^{3+}$ electron spin. This work demonstrates the fundamental equivalence of electric and magnetic density of states engineering, and provides a new tool for controlling light-matter interactions for a broader class of emitters

The Angular Correlation Function of Galaxies from Early SDSS Data

The Sloan Digital Sky Survey is one of the first multicolor photometric and spectroscopic surveys designed to measure the statistical properties of galaxies within the local Universe. In this Letter we present some of the initial results on the angular 2-point correlation function measured from the early SDSS galaxy data. The form of the correlation function, over the magnitude interval 18<r*<22, is shown to be consistent with results from existing wide-field, photographic-based surveys and narrower CCD galaxy surveys. On scales between 1 arcminute and 1 degree the correlation function is well described by a power-law with an exponent of ~ -0.7. The amplitude of the correlation function, within this angular interval, decreases with fainter magnitudes in good agreement with analyses from existing galaxy surveys. There is a characteristic break in the correlation function on scales of approximately 1-2 degrees. On small scales, < 1', the SDSS correlation function does not appear to be consistent with the power-law form fitted to the 1'< theta <0.5 deg data. With a data set that is less than 2% of the full SDSS survey area, we have obtained high precision measurements of the power-law angular correlation function on angular scales 1' < theta < 1 deg, which are robust to systematic uncertainties. Because of the limited area and the highly correlated nature of the error covariance matrix, these initial results do not yet provide a definitive characterization of departures from the power-law form at smaller and larger angles. In the near future, however, the area of the SDSS imaging survey will be sufficient to allow detailed analysis of the small and large scale regimes, measurements of higher-order correlations, and studies of angular clustering as a function of redshift and galaxy type

The Splicing Efficiency of Activating HRAS Mutations Can Determine Costello Syndrome Phenotype and Frequency in Cancer

Costello syndrome (CS) may be caused by activating mutations in codon 12/13 of the HRAS proto-oncogene. HRAS p.Gly12Val mutations have the highest transforming activity, are very frequent in cancers, but very rare in CS, where they are reported to cause a severe, early lethal, phenotype. We identified an unusual, new germline p.Gly12Val mutation, c.35_36GC>TG, in a 12-year-old boy with attenuated CS. Analysis of his HRAS cDNA showed high levels of exon 2 skipping. Using wild type and mutant HRAS minigenes, we confirmed that c.35_36GC>TG results in exon 2 skipping by simultaneously disrupting the function of a critical Exonic Splicing Enhancer (ESE) and creation of an Exonic Splicing Silencer (ESS). We show that this vulnerability of HRAS exon 2 is caused by a weak 3' splice site, which makes exon 2 inclusion dependent on binding of splicing stimulatory proteins, like SRSF2, to the critical ESE. Because the majority of cancer- and CS- causing mutations are located here, they affect splicing differently. Therefore, our results also demonstrate that the phenotype in CS and somatic cancers is not only determined by the different transforming potentials of mutant HRAS proteins, but also by the efficiency of exon 2 inclusion resulting from the different HRAS mutations. Finally, we show that a splice switching oligonucleotide (SSO) that blocks access to the critical ESE causes exon 2 skipping and halts proliferation of cancer cells. This unravels a potential for development of new anti-cancer therapies based on SSO-mediated HRAS exon 2 skipping